がんバイオプシー市場：製品別（機器、キット・消耗品、サービス）、タイプ別（リキッドバイオプシー、組織バイオプシー）-2023-2030年の世界予測

がんバイオプシーの世界市場は、2023年に298億4,000万米ドル、CAGR12.26%で大幅な成長が予測され、2030年には驚異的な671億4,000万米ドルに達する見込みです。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のがんバイオプシー市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客ベース、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.がんバイオプシーの世界市場規模および予測は？

2.予測期間中、世界のがんバイオプシー市場を形成するCOVID-19の阻害要因と影響は？

3.がんバイオプシーの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.がんバイオプシーの世界市場における競争戦略は？

5.がんバイオプシーの世界市場における技術動向と規制の枠組みは？

6.がんバイオプシーの世界市場における主要ベンダーの市場シェアは？

7.がんバイオプシーの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 非侵襲的処置に対する嗜好の増加
    • がん生検と組織切片の新たな重要性
    • がん患者別リキッドバイオプシーの採用の増加
  • 抑制要因
    • 感度と特異度が低い
  • 機会
    • 画像誘導生検における一連の進歩
    • がんバイオプシー開発のための研究開発を強化
  • 課題
    • 不明確な規制と償還シナリオ
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 がんバイオプシー市場：製品別

• 機器
• キットと消耗品
• サービス

第7章 がんバイオプシー市場：タイプ別

• リキッドバイオプシー
• 組織生検
  • 針生検
    • コア針生検
    • 細針吸引
  • 外科的生検

第8章 南北アメリカのがんバイオプシー市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のがんバイオプシー市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのがんバイオプシー市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第12章 掲載企業一覧

第13章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. CANCER BIOPSY MARKET RESEARCH PROCESS
• FIGURE 2. CANCER BIOPSY MARKET SIZE, 2022 VS 2030
• FIGURE 3. CANCER BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. CANCER BIOPSY MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 6. CANCER BIOPSY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. CANCER BIOPSY MARKET DYNAMICS
• FIGURE 8. CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. CANCER BIOPSY MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS CANCER BIOPSY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES CANCER BIOPSY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC CANCER BIOPSY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA CANCER BIOPSY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. CANCER BIOPSY MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. CANCER BIOPSY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. CANCER BIOPSY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. CANCER BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. CANCER BIOPSY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. CANCER BIOPSY MARKET SIZE, BY KITS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. CANCER BIOPSY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 9. CANCER BIOPSY MARKET SIZE, BY LIQUID BIOPSIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 11. CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 13. CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. CANCER BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY , BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. CANCER BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION , BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. CANCER BIOPSY MARKET SIZE, BY SURGICAL BIOPSIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS CANCER BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 30. CANADA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. CANADA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 33. CANADA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES CANCER BIOPSY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC CANCER BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 52. CHINA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. CHINA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. CHINA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 55. CHINA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 56. INDIA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. INDIA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. INDIA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 59. INDIA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 60. INDONESIA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. INDONESIA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. INDONESIA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 64. JAPAN CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. JAPAN CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. JAPAN CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 68. MALAYSIA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. MALAYSIA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. MALAYSIA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 72. PHILIPPINES CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. PHILIPPINES CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. PHILIPPINES CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 76. SINGAPORE CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. SINGAPORE CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. SINGAPORE CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 80. SOUTH KOREA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. SOUTH KOREA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. SOUTH KOREA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 84. TAIWAN CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. TAIWAN CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. TAIWAN CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 88. THAILAND CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. THAILAND CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. THAILAND CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 92. VIETNAM CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. VIETNAM CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. VIETNAM CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 96. EUROPE, MIDDLE EAST & AFRICA CANCER BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 97. EUROPE, MIDDLE EAST & AFRICA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. EUROPE, MIDDLE EAST & AFRICA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 101. DENMARK CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. DENMARK CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. DENMARK CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 105. EGYPT CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. EGYPT CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. EGYPT CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 109. FINLAND CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. FINLAND CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. FINLAND CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 113. FRANCE CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. FRANCE CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. FRANCE CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 117. GERMANY CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. GERMANY CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. GERMANY CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 121. ISRAEL CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. ISRAEL CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. ISRAEL CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 125. ITALY CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. ITALY CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. ITALY CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 128. ITALY CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 129. NETHERLANDS CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. NETHERLANDS CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. NETHERLANDS CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 133. NIGERIA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. NIGERIA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. NIGERIA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 137. NORWAY CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. NORWAY CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NORWAY CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 141. POLAND CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. POLAND CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. POLAND CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 144. POLAND CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 145. QATAR CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. QATAR CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. QATAR CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 148. QATAR CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 149. RUSSIA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. RUSSIA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. RUSSIA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 153. SAUDI ARABIA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. SAUDI ARABIA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. SAUDI ARABIA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 157. SOUTH AFRICA CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. SOUTH AFRICA CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. SOUTH AFRICA CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 161. SPAIN CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. SPAIN CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SPAIN CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 165. SWEDEN CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. SWEDEN CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SWEDEN CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 169. SWITZERLAND CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. SWITZERLAND CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SWITZERLAND CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 173. TURKEY CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. TURKEY CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. TURKEY CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 177. UNITED ARAB EMIRATES CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. UNITED ARAB EMIRATES CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. UNITED ARAB EMIRATES CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 181. UNITED KINGDOM CANCER BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. UNITED KINGDOM CANCER BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. UNITED KINGDOM CANCER BIOPSY MARKET SIZE, BY TISSUE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM CANCER BIOPSY MARKET SIZE, BY NEEDLE BIOPSIES, 2018-2030 (USD MILLION)
• TABLE 185. CANCER BIOPSY MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 186. CANCER BIOPSY MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 187. CANCER BIOPSY MARKET LICENSE & PRICING

The Global Cancer Biopsy Market is forecasted to grow significantly, with a projected USD 29.84 billion in 2023 at a CAGR of 12.26% and expected to reach a staggering USD 67.14 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cancer Biopsy Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cancer Biopsy Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Instruments, Kits & Consumables, and Services. The Instruments is projected to witness significant market share during forecast period.

Based on Type, market is studied across Liquid Biopsies and Tissue Biopsies. The Tissue Biopsies is further studied across Needle Biopsies and Surgical Biopsies. The Needle Biopsies is further studied across Core Needle Biopsy and Fine Needle Aspiration. The Tissue Biopsies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cancer Biopsy Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cancer Biopsy Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cancer Biopsy Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cancer Biopsy Market?

4. What is the competitive strategic window for opportunities in the Global Cancer Biopsy Market?

5. What are the technology trends and regulatory frameworks in the Global Cancer Biopsy Market?

6. What is the market share of the leading vendors in the Global Cancer Biopsy Market?

7. What modes and strategic moves are considered suitable for entering the Global Cancer Biopsy Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Cancer Biopsy Market, by Product, 2022 vs 2030
• 4.3. Cancer Biopsy Market, by Type, 2022 vs 2030
• 4.4. Cancer Biopsy Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing preference for non invasive procedures
    • 5.1.1.2. Emerging significance of cancer biopsies and tissue sectioning
    • 5.1.1.3. Growing adoption of liquid biopsies by cancer patients
  • 5.1.2. Restraints
    • 5.1.2.1. Low sensitivity and specificity
  • 5.1.3. Opportunities
    • 5.1.3.1. Series of advancements in image-guided biopsies
    • 5.1.3.2. Increasing R&D for development of cancer biopsy
  • 5.1.4. Challenges
    • 5.1.4.1. Unclear regulatory and reimbursement scenarios
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Cancer Biopsy Market, by Product

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Kits & Consumables
• 6.4. Services

7. Cancer Biopsy Market, by Type

• 7.1. Introduction
• 7.2. Liquid Biopsies
• 7.3. Tissue Biopsies
  • 7.3.1. Needle Biopsies
    • 7.3.1.1. Core Needle Biopsy
    • 7.3.1.2. Fine Needle Aspiration
  • 7.3.2. Surgical Biopsies

8. Americas Cancer Biopsy Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Cancer Biopsy Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Cancer Biopsy Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing